Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Non-Current Liabilities (2016 - 2025)

Collegium Pharmaceutical has reported Total Non-Current Liabilities over the past 7 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 5.47% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 5.47%, while the annual FY2025 figure was $1.4 billion, 5.47% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $1.4 billion at Collegium Pharmaceutical, up from $1.3 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.4 billion in Q4 2024 and troughed at $947.9 million in Q4 2023.
  • A 3-year average of $1.3 billion and a median of $1.4 billion in 2025 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 51.24% in 2024 and later decreased 5.47% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $947.9 million in 2023, then soared by 51.24% to $1.4 billion in 2024, then dropped by 5.47% to $1.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for COLL at $1.4 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.4 billion in Q2 2025.